Full Press Release Details
Melbourne (Australia) and Indianapolis (United States) | 12 January 2026
Telix is pleased to provide a copy of the presentation that will be delivered by Dr. Christian Behrenbruch, Managing Director and Group CEO at the 44 th Annual J.P. Morgan Healthcare Conference being held in San Francisco, CA (U.S.).
The presentation takes place on Monday, 12 January at 9:00 am PST (12:00 pm EST / 4:00 am AEDT, 13 January 2026).
The event will be webcast live here and available on demand for 30 days via the Telix Investor Relations website at ir.telixpharma.com.
Telix has also published a comprehensive overview of all therapeutic pipeline assets in a dedicated presentation accessible on the Investor Relations website.
Financials for the fourth quarter of 2025, will be released on 20 January, 2026.
Download the full presentation here